etoricoxib

An interesting article titled “Does low dose of etoricoxib play pre-emptive analgesic efect in third molar surgery? A randomized clinical trial” written by Long Xie and et al. appears in BMC Oral Health (vol. 21, no. 462, 2021). The article discusses the results of a randomized clinical trial that explored if a preemptive low dose of the nonsteroidal anti-inflammatory drug (NSAID) etoricoxib may reduce the need for analgesics after wisdom teeth extraction. The study the authors conducted was designed as randomized, parallel, double-blinded and placebo-controlled and occurred between August 2019 and July 2020. A total of 56 patients were included in the study that met the inclusion criteria and scheduled to have impacted horizontal mandibular wisdom teeth extracted. The authors found that the mean VAS pain score in the etoricoxib group was significantly lower than that in the placebo group … Read more